ArticleJournal of cardiovascular development and disease2026
EBF1 Regulates Cardiac Development Through Fibroblast to Myocyte Signaling.
Article in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The transcription factor early B-cell factor 1 (EBF1) plays critical developmental roles in numerous organ systems, including B-cells, kidney, bone, and heart. During cardiogenesis, cardiomyocyte expression of EBF1 is reportedly undetectable and its effects on myocyte development and proliferation are thought to reflect a non-cell autonomous mechanism, acting via intercellular communication from EBF1 expressing non-myocyte cells. Here, using single-cell transcriptional profiling, we confirm the absence of Ebf1 transcripts in cardiomyocytes. Furthermore, employing computational receptor-ligand interaction analysis of dissociated cells from wildtype and EBF1-deficient hearts, we show that loss of function of this pioneer transcription factor enhances fibroblast to myocyte signaling via the collagen-integrin pathway. Finally, we generated fibroblast-specific EBF1 knockout mice using a PDGFRα-Cre transgenic driver, and found a nearly identical phenotype to that of the generalized knockout, with runting, premature death, an increase in left ventricular relative wall thickness and cardiomyocyte hyperplasia. These findings provide further mechanistic insight into the non-cell autonomous mechanism of action of EBF1 in cardiac growth and development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.